Tag: Association for Accessible Medicines

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Association for Accessible Medicines

Biosimilars Market to Witness Massive growth ahead | Novartis (Sandoz),

Added to Collection on: 2021-05-24 07:30:00

Tags for this article:

Life Sciences
Biotechnology
Health sciences
Biosimilar
Biopharmaceutical
Novartis
Market segmentation
Food and Drug Administration
Association for Accessible Medicines

Click the tags to see associated articles and topics

View Article Details
People, Process, Platforms: “EUniting” the spectrum of Innovation in European healthcare

Added to Collection on: 2021-07-19 13:52:30

Tags for this article:

Articles
Life Sciences
Innovation economics
Biotechnology
Innovation
Biosimilar
Drugs
Novartis
Association for Accessible Medicines
Rebecca Kees Roks

Click the tags to see associated articles and topics

View Article Details
Drug pricing bills shouldn't undermine savings from generics, biosimilars - Stat News

Added to Collection on: 2021-11-06 16:08:41

Tags for this article:

Life Sciences
Health sciences
Health care
Pharmaceuticals policy
Pharmaceutical industry
Pharmacy
Biotechnology
Drugs
Association for Accessible Medicines
Biosimilar
Generic drug
Prescription drug

Click the tags to see associated articles and topics

View Article Details
Big Pharma is betting on bigger political ambitions from Sen. Tim Scott - MedCity News

Added to Collection on: 2022-03-29 04:38:34

Tags for this article:

Legislatures
Members of the United States Congress
Health sciences
Female members of the United States House of Representatives
Pharmaceuticals policy
Bisexual women
Kyrsten Sinema
Pharmaceutical industry
Association for Accessible Medicines
Cathy McMorris Rodgers
Ron Wyden
Pharma
United States
Tim Scott

Click the tags to see associated articles and topics

View Article Details
What are biosimilars and why are pharma companies so bullish on them? - BusinessToday

Added to Collection on: 2022-10-23 10:11:04

Tags for this article:

Life Sciences
Articles
Biotechnology
CNX Nifty
Pharmaceutical industry
Biosimilar
Drugs
Biopharmaceutical
Dr. Reddy's Laboratories
Cipla
Teva Pharmaceutical Industries
Association for Accessible Medicines

Click the tags to see associated articles and topics

View Article Details
WHO Biosimilar Guidelines Are A Tepid Attempt To Improve Access And Affordability

Added to Collection on: 2022-11-12 07:17:38

Tags for this article:

Life Sciences
Articles
Biotechnology
Specialty drugs
Biosimilar
Drugs
Pharmaceutical industry
RTT
Biopharmaceutical
Trastuzumab
Biocon
Association for Accessible Medicines
United States

Click the tags to see associated articles and topics

View Article Details
AAM's Dan Leonard, president of generic drug lobby, ousted - STAT News

Added to Collection on: 2022-12-03 21:06:31

Tags for this article:

Health
Articles
Pharmaceutical industry
Pharmaceuticals policy
Healthcare reform in the United States
Association for Accessible Medicines
Pharmacy
AAM
Medicare
Medication
Generic drug

Click the tags to see associated articles and topics

View Article Details
Safety Outcomes When “Switching” Between Biosimilars and Reference Products | FDA

Added to Collection on: 2023-12-05 22:20:59

Tags for this article:

Pharmaceutical industry
Biotechnology products
Specialty drugs
Monoclonal antibodies
Immunosuppressants
Biosimilar
Biopharmaceutical
Biologics license application
Biologics Price Competition and Innovation Act
Association for Accessible Medicines
Adalimumab

Click the tags to see associated articles and topics

View Article Details
Strategies to Boost Biosimilar Adoption and Improve Patient Access

Added to Collection on: 2024-10-17 16:32:38

Tags for this article:

Biopharmaceuticals
Biosimilar
Biotechnology
Biotechnology products
Pharmaceutical industry
Specialty drugs
Academy of Managed Care Pharmacy
Adalimumab
Medicare
Pharmacy benefit management
Association for Accessible Medicines
Specialty drugs in the United States
Sophia Humphreys
Justin Bioc

Click the tags to see associated articles and topics

View Article Details
Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics ...

Added to Collection on: 2024-11-15 22:18:43

Tags for this article:

Specialty drugs
Biopharmaceuticals
Biosimilar
Biotechnology
Trastuzumab
Pharmaceutical industry in India
Novartis
Biogen
Viatris
Sarfaraz K. Niazi
Association for Accessible Medicines

Click the tags to see associated articles and topics

View Article Details